Lipoprotein(A) and coronary disease—moving closer to causality

Nature Reviews Cardiology

Volumn 6, Issue 9, 2009, Pages 565-567

  Danesh, John ^a   Erqou, Sebhat ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; LIPOPROTEIN A;

BLOOD; CORONARY ARTERY DISEASE; EVIDENCE BASED MEDICINE; GENETIC PREDISPOSITION; GENETICS; HUMAN; NOTE; PHENOTYPE; RISK ASSESSMENT; RISK FACTOR; UPREGULATION;

BIOLOGICAL MARKERS; CORONARY DISEASE; EVIDENCE-BASED MEDICINE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIPOPROTEIN(A); PHENOTYPE; RISK ASSESSMENT; RISK FACTORS; UP-REGULATION;

EID: 70350703412     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2009.138     Document Type: Article

References (10)

1. Anuurad, E., Boffa, M. B., Koschinsky, M. L. & Berglund, L. Lipoprotein(a): a unique risk factor for cardiovascular disease. Clin. Lab. Med. 26, 751-772 (2006).
2. Berg, K. A new serum type system in man—the Lp system. Acta Pathol. Microbiol. Scand. 59, 369-382 (1963).
3. Kamstrup, P R., Tybjaerg-Hansen, A., Steffensen, R. & Nordestgaard, B. G. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 301, 2331-2339 (2009).
4. Barnathan, E. S. Has lipoprotein ‘little’ (a) shrunk? JAMA 270, 2224-2225 (1993).
5. Marcovina, S.M., Koschinsty, M.L., Albers, J. J., Skarlatos, S.; Report of the National Heart, Lung, and Blood institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions. Clin. Chem. 49, 1785-1796 (2003).
6. Bennet, A. et al. Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data. Arch. Intern. Med. 168, 598-608 (2008).
7. The Emerging Risk Factors Collaboration. Lipoprotein (a) and risk of coronary heart disease and ischemic stroke. JAMA 302, 412-423 (2009).
8. Keavney, B. et al. Fibrinogen and coronary heart disease: test of causality by ‘Mendelian randomization’. Int. J. Epidemiol. 35, 935-943 (2006).
9. Tregouet, D. A. et al. Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat. Genet. 41, 283-285 (2009).
10. Tsimikas, S., Tsironis, L. D. & Tselepis, A D. New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 27, 2094-2099 (2007).